217 related articles for article (PubMed ID: 28690072)
1. Identity of Gli1
Sena IFG; Prazeres PHDM; Santos GSP; Borges IT; Azevedo PO; Andreotti JP; Almeida VM; Paiva AE; Guerra DAP; Lousado L; Souto L; Mintz A; Birbrair A
Exp Hematol; 2017 Oct; 54():12-16. PubMed ID: 28690072
[TBL] [Abstract][Full Text] [Related]
2. Gli1
Schneider RK; Mullally A; Dugourd A; Peisker F; Hoogenboezem R; Van Strien PMH; Bindels EM; Heckl D; Büsche G; Fleck D; Müller-Newen G; Wongboonsin J; Ventura Ferreira M; Puelles VG; Saez-Rodriguez J; Ebert BL; Humphreys BD; Kramann R
Cell Stem Cell; 2017 Jun; 20(6):785-800.e8. PubMed ID: 28457748
[TBL] [Abstract][Full Text] [Related]
3. LepR+ cells dispute hegemony with Gli1+ cells in bone marrow fibrosis.
Sena IFG; Borges IT; Lousado L; Azevedo PO; Andreotti JP; Almeida VM; Paiva AE; Santos GSP; Guerra DAP; Prazeres PHDM; Souto L; Mintz A; Birbrair A
Cell Cycle; 2017; 16(21):2018-2022. PubMed ID: 28976809
[TBL] [Abstract][Full Text] [Related]
4. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
Gleitz HF; Kramann R; Schneider RK
J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
[TBL] [Abstract][Full Text] [Related]
5. Targeting GLI1 Suppresses Cell Growth and Enhances Chemosensitivity in CD34+ Enriched Acute Myeloid Leukemia Progenitor Cells.
Long B; Wang LX; Zheng FM; Lai SP; Xu DR; Hu Y; Lin DJ; Zhang XZ; Dong L; Long ZJ; Tong XZ; Liu Q
Cell Physiol Biochem; 2016; 38(4):1288-302. PubMed ID: 27008269
[TBL] [Abstract][Full Text] [Related]
6. CDK6 Is a Therapeutic Target in Myelofibrosis.
Dutta A; Nath D; Yang Y; Le BT; Mohi G
Cancer Res; 2021 Aug; 81(16):4332-4345. PubMed ID: 34145036
[TBL] [Abstract][Full Text] [Related]
7. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
[TBL] [Abstract][Full Text] [Related]
8. GLI1 activates pro-fibrotic pathways in myelofibrosis fibrocytes.
Manshouri T; Veletic I; Li P; Yin CC; Post SM; Verstovsek S; Estrov Z
Cell Death Dis; 2022 May; 13(5):481. PubMed ID: 35595725
[TBL] [Abstract][Full Text] [Related]
9. Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN.
Gleitz HFE; Dugourd AJF; Leimkühler NB; Snoeren IAM; Fuchs SNR; Menzel S; Ziegler S; Kröger N; Triviai I; Büsche G; Kreipe H; Banjanin B; Pritchard JE; Hoogenboezem R; Bindels EM; Schumacher N; Rose-John S; Elf S; Saez-Rodriguez J; Kramann R; Schneider RK
Blood; 2020 Oct; 136(18):2051-2064. PubMed ID: 32726410
[TBL] [Abstract][Full Text] [Related]
10. Systematic dissection of coordinated stromal remodeling identifies Sox10
Sarkaria SM; Zhou J; Bao S; Zhao W; Fang Y; Que J; Bhagat G; Zhang C; Ding L
Cell Stem Cell; 2023 Jun; 30(6):832-850.e6. PubMed ID: 37267917
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.
Zahr AA; Salama ME; Carreau N; Tremblay D; Verstovsek S; Mesa R; Hoffman R; Mascarenhas J
Haematologica; 2016 Jun; 101(6):660-71. PubMed ID: 27252511
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
[TBL] [Abstract][Full Text] [Related]
13. The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.
Kramann R; Schneider RK
Blood; 2018 May; 131(19):2111-2119. PubMed ID: 29572380
[TBL] [Abstract][Full Text] [Related]
14. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
Shahi MH; Farheen S; Mariyath MP; Castresana JS
Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
[TBL] [Abstract][Full Text] [Related]
15. From cell to cell: Identification of actionable targets in bone marrow fibrosis using single-cell technologies.
Leimkühler NB; Costa IG; Schneider RK
Exp Hematol; 2021 Dec; 104():48-54. PubMed ID: 34601067
[TBL] [Abstract][Full Text] [Related]
16. GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3.
Geng L; Lu K; Li P; Li X; Zhou X; Li Y; Wang X
Oncotarget; 2017 Jul; 8(30):48701-48710. PubMed ID: 27275540
[TBL] [Abstract][Full Text] [Related]
17. GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia.
Zhou C; Du J; Zhao L; Liu W; Zhao T; Liang H; Fang P; Zhang K; Zeng H
Cell Death Dis; 2021 Mar; 12(3):231. PubMed ID: 33658491
[TBL] [Abstract][Full Text] [Related]
18. PPARγ agonists promote the resolution of myelofibrosis in preclinical models.
Lambert J; Saliba J; Calderon C; Sii-Felice K; Salma M; Edmond V; Alvarez JC; Delord M; Marty C; Plo I; Kiladjian JJ; Soler E; Vainchenker W; Villeval JL; Rousselot P; Prost S
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33914703
[TBL] [Abstract][Full Text] [Related]
19. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.
Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA
Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.
Mani C; Tripathi K; Chaudhary S; Somasagara RR; Rocconi RP; Crasto C; Reedy M; Athar M; Palle K
Neoplasia; 2021 Sep; 23(9):1002-1015. PubMed ID: 34380074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]